[1]
“Development of Machine Learning Platforms that Accelerate Drug Discovery and Molecular Screening for Cancers, Autoimmune Diseases, And Neurological Disorders”, AJEMA, vol. 3, no. 12, pp. 8–18, Dec. 2025, Accessed: Feb. 04, 2026. [Online]. Available: https://www.grnjournal.us/index.php/AJEMA/article/view/8731